The Antiepileptic Drugs Market: Navigating Growth in Neurological Healthcare
The global antiepileptic drugs (AED) market represents one of the most critical segments in neurological healthcare, addressing the needs of over 50 million people worldwide who live with epilepsy. This market has experienced steady growth over the past decade and continues to evolve with innovative therapeutic approaches and improved patient outcomes at its core. Request a Sample: https://www.futurewiseresearch.com/contact.aspx?rpt=10238&type=requestsample Market Landscape and Size The antiepileptic drugs market has demonstrated remarkable resilience and growth, driven primarily by increasing epilepsy prevalence, improved diagnostic capabilities, and enhanced awareness of neurological disorders. The market encompasses both traditional first-generation drugs like phenytoin and carbamazepine, as well as newer third-generation medications such as lacosamide and perampanel, which offer improved efficacy profiles and reduced side effects. Geographic distribution shows sig...